High carbon margins offset pavement headwinds as portfolio cleanup stalls
- The core profit engine is Performance Materials, where Q3 2026 segment EBITDA margins reached 54.1 percent.
- The sale process for the Advanced Polymer Technologies segment has been delayed, with an announcement now expected in early 2027.
- A 50 percent increase in US asphalt costs is forcing customers to delay new paving projects in favor of maintenance.
- A municipal water treatment contract for PFAS filtration and new biogas projects open long-term growth markets outside of automotive.
The smaller company hits a speed bump
Ingevity is trying to become New Ingevity, a smaller and cleaner chemicals company built around two businesses: Performance Materials and Pavement Technologies. The bull case is that this plan makes the good parts easier to see. Performance Materials is highly profitable, hitting a 54.1 percent EBITDA margin in Q3 2026. The segment gets help from buyers choosing hybrid vehicles instead of battery electric vehicles, and commercial adoption in biogas purification and PFAS filtration provides a growth path that does not depend on cars.
The bear case remains focused on execution delays and raw material costs. Advanced Polymer Technologies, or APT, is still waiting to be sold. Management expects the announcement of a deal to extend into early 2027 as they try to secure a better valuation. A weak deal or no deal would keep the main execution risk alive.
Operating headwinds are also increasing. Higher asphalt prices have surged nearly 50 percent this year in some US regions. This inflation forces road contractors to spend their limited budgets on basic maintenance instead of new paving, introducing a severe near-term headwind for the Pavement Technologies segment.
High-margin carbon, road additives, and exits
Ingevity makes money by selling specialty chemical products to industrial customers. Its most valuable business is Performance Materials, which sells hardwood-based activated carbon used in gasoline vapor control systems and filtration. This segment drives the bulk of company profits, supported by price increases and hybrid vehicle demand.
Pavement Technologies sells additives and tools used in asphalt construction, preservation, and recycling. This business depends on road budgets, contractor activity, and the price of asphalt itself. When crude oil inflation drives asphalt costs up, as seen in late 2026, customers cut back on expensive new paving projects.
The model can break if the simplification plan stalls. Road markings was sold to PPG for 65 million dollars, and industrial specialties for 93 million dollars. APT remains the bigger open item. If that sale fails to secure a favorable multiple, or if the remaining 10 million dollars of stranded costs stay in the business, the go-forward margin profile will look less clean than the bull case expects.
What stays, what goes
Automotive activated carbon
This is the core Performance Materials product line. It helps control gasoline vapor emissions in internal combustion and hybrid vehicles, and it drives very high segment margins.
Filtration activated carbon
Ingevity sells activated carbon for food, water, and chemical filtration. Municipal contracts for PFAS water treatment and accelerating biogas projects validate this as a major growth vector.
Pavement Technologies
This product line sells asphalt additives and road technologies. It is a core part of New Ingevity, though highly sensitive to asphalt costs that currently restrict customer budgets.
Advanced Polymer Technologies
APT makes caprolactone-based polymers used in end markets like automotive, footwear, and industrial products. The segment is awaiting a sale expected in early 2027.
Mix before the next sale
Segment shares use Q1 2026 net sales from continuing operations: Performance Materials 155.4 million dollars, Performance Chemicals 58.3 million dollars, and APT 44.3 million dollars. The mix will change when APT is sold.
What could still go wrong
APT sale delays or disappoints
High impact · Medium oddsAPT is the largest remaining piece of the portfolio cleanup. The sale process has been delayed to early 2027. A complex deal structure or weak end markets could reduce the valuation, or leave Ingevity owning a weaker business longer than planned.
High asphalt prices crush pavement demand
Medium impact · High oddsHigher oil prices pushed US asphalt prices up nearly 50 percent in 2026. This severely slowed pavement opportunities as customers shifted finite budgets to road maintenance instead of new paving.
EV shift cuts the carbon runway
High impact · Medium oddsPerformance Materials depends on internal combustion and hybrid vehicles because its carbon products control gasoline vapors. The business currently benefits from a consumer shift toward hybrids, but a faster move to battery electric vehicles would shrink the need for this product.
Stranded costs stay too high
Medium impact · Medium oddsSelling businesses does not remove every related cost on day one. Ingevity must eliminate 20 million dollars of indirect costs from recent sales. It removed 10 million dollars by mid-2026, but missing the rest would pressure New Ingevity margins.
In one breath
What does Ingevity actually make?
Ingevity makes specialty chemical products. Its key products include activated carbon for gasoline vapor control and water filtration, asphalt additives for roads, and caprolactone-based polymers in APT.
Why is Ingevity selling businesses?
Management wants to create New Ingevity, a simpler company focused on higher-margin areas. It sold industrial specialties and road markings, and APT is awaiting a sale expected in early 2027.
Why do hybrid cars matter for NGVT?
Hybrids still use gasoline engines, so they need vapor control systems that use Ingevity activated carbon. That helps Performance Materials buy time while the company develops new markets like PFAS filtration.
What is the biggest near-term catalyst?
The biggest catalyst is a clear outcome for APT. A sale at a fair price would make the portfolio cleaner, while further delays would keep the main execution risk alive.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- November 8, 2026
- Score data
- November 15, 2026
- Reviewed by
- Shivam Bharuka
Comparable Specialty Chemicals companies
Companies near Ingevity Corporation in Finn's Specialty Chemicals industry ranking.

